跳至主要内容
临床试验/DRKS00033331
DRKS00033331招募中不适用

Advanced Glycation Endproducts (AGEs) and their impact on transport proteins, inflammation and body composition of hemodialysis patients compared to healthy subjects - AGEs and transport proteins

Martin-Luther-Universität Halle-Wittenberg, Universitätsmedizin Halle, Klinik für Innere Medizin II0 个研究点目标入组 30 人开始时间: 2024年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • a) healthy subjects (Group A, young people)
  • - Age: > 18 to 30 years inclusive
  • - written informed consent
  • b) healthy subjects (Group B, moderate old people)
  • - Age: > 40 to 70 years inclusive
  • - written informed consent
  • c) moderate old hemodialysis patients (Group C)
  • - Age: > 40 to 70 years inclusive
  • - written informed consent
  • - endstage renal disease, hemodialysis therapy for at least 3 months

排除标准

  • a) healthy subjects (Group A, young people)
  • - known malignant tumor disease
  • - impaired kidney function (eGFR < 60 ml/min)
  • - acute infection (CRP > 50mg/l, fever, chills)
  • - Diabetes mellitus (HbA1c < 40 mmol/mol IFCC)
  • - psychiatric or neurological illnesses that impair the ability to consent
  • - known pregnancy or lack of contraception (premenopausal women)
  • b) healthy subjects (Group B, moderate old people)
  • - known malignant tumor disease
  • - impaired kidney function (eGFR < 60 ml/min)
  • - acute infection (CRP > 50mg/l, fever, chills)
  • - Diabetes mellitus (HbA1c < 40 mmol/mol IFCC)
  • - psychiatric or neurological illnesses that impair the ability to consent
  • - known pregnancy or lack of contraception (premenopausal women)
  • c) moderate old hemodialysis patients (Group C)
  • - known malignant tumor disease
  • - acute infection (CRP > 50mg/l, fever, chills)
  • - Diabetes mellitus (HbA1c < 40 mmol/mol IFCC)
  • - psychiatric or neurological illnesses that impair the ability to consent
  • - known pregnancy or lack of contraception (premenopausal women)

研究者

发起方
Martin-Luther-Universität Halle-Wittenberg, Universitätsmedizin Halle, Klinik für Innere Medizin II

相似试验